These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 26549592)

  • 41. [New insights into molecular target therapy for colorectal cancer].
    Kanemitsu K; Yamashita K; Sumi Y; Suzuki S; Tanaka K; Kakeji Y
    Nihon Shokakibyo Gakkai Zasshi; 2012 Dec; 109(12):2021-30. PubMed ID: 23221050
    [No Abstract]   [Full Text] [Related]  

  • 42. Current status and problems of molecular target therapy for colorectal cancer.
    Tsuda T; Nakajima T; Boku N
    Nihon Shokakibyo Gakkai Zasshi; 2011 Jan; 108(1):19-23. PubMed ID: 21212591
    [No Abstract]   [Full Text] [Related]  

  • 43. Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
    Hasbullah HH; Musa M
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.
    Li Y; Liu Y; Xu H; Jiang G; Van der Jeught K; Fang Y; Zhou Z; Zhang L; Frieden M; Wang L; Luo Z; Radovich M; Schneider BP; Deng Y; Liu Y; Huang K; He B; Wang J; He X; Zhang X; Ji G; Lu X
    Nat Commun; 2018 Oct; 9(1):4394. PubMed ID: 30349055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations.
    Yaglom JA; Wang Y; Li A; Li Z; Monti S; Alexandrov I; Lu X; Sherman MY
    Sci Rep; 2018 Feb; 8(1):3010. PubMed ID: 29445088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TP53 loss creates therapeutic vulnerability in colorectal cancer.
    Liu Y; Zhang X; Han C; Wan G; Huang X; Ivan C; Jiang D; Rodriguez-Aguayo C; Lopez-Berestein G; Rao PH; Maru DM; Pahl A; He X; Sood AK; Ellis LM; Anderl J; Lu X
    Nature; 2015 Apr; 520(7549):697-701. PubMed ID: 25901683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Colorectal cancer: POLR2A deletion with TP53 opens a window of opportunity for therapy.
    Errico A
    Nat Rev Clin Oncol; 2015 Jul; 12(7):374. PubMed ID: 25985938
    [No Abstract]   [Full Text] [Related]  

  • 48. Colorectal cancer: A circuitous way to target p53.
    Seton-Rogers S
    Nat Rev Cancer; 2015 Jun; 15(6):318-9. PubMed ID: 25971675
    [No Abstract]   [Full Text] [Related]  

  • 49. A new way to target p53-defective colorectal cancer.
    Liu Y; Wang L; Lu X
    Future Oncol; 2015; 11(23):3101-4. PubMed ID: 26549592
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug resistance and new therapies in colorectal cancer.
    Van der Jeught K; Xu HC; Li YJ; Lu XB; Ji G
    World J Gastroenterol; 2018 Sep; 24(34):3834-3848. PubMed ID: 30228778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biomarkers and targeted therapeutics in colorectal cancer.
    Meguerditchian AN; Bullard Dunn K
    Surg Oncol Clin N Am; 2013 Oct; 22(4):841-55. PubMed ID: 24012402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immunohistologic evaluation of TS, DPD, and p53 protein expression in patients with colorectal cancer having liver and pulmonary metastases].
    Ishida H; Sadahiro S; Tajima T; Makuuchi H
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():233-6. PubMed ID: 14574888
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.